Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Oil, Lehman, Housing, & Fedspeak
Jun 09, 2008 10:02 AM
- Alseres Pharmaceuticals, Inc. Reports First Quarter 2008 Operational and Financial Results and XOMA to Present At the Rodman and Renshaw Global Healthcare Conference On May 20
May 14, 2008 07:29 PM
- Analyst Comments: Priceline, XOMA, Red Robin, Right Path, Halliburton
May 13, 2008 10:47 AM
- Market Review for the Week
May 11, 2008 11:26 PM
- XOMA Platform Far Undervalued
Mar 12, 2008 12:30 PM
- Look for Multi-Use Biotech Drugs
Dec 12, 2007 02:47 PM
- XOMA Announces Conference Call to Provide Overview of Business Strategy and Pharmacopeia To Present at BMO Capital Markets' Seventh Annual Focus on Healthcare Conference
Nov 27, 2007 09:28 AM
- XOMA Sell-Off an Opportunity
Aug 09, 2007 06:18 PM
- NASDAQ Technical Picture - Bulls Regain Momentum
Aug 09, 2007 02:15 AM
- Gilead Begin Enrollment For Clinical Study of HIV Integrase Inhibitor and Immune Response Corporation's NeuroVax Show Promise in Preliminary Clinical Trial
Jun 22, 2005 10:01 AM
- XOMA Reports Third Quarter 2008 Financial Results
Nov 10, 2008 04:01 PM
- XOMA Restructures Drug Development Collaboration Including Oncology Drug Candidate HCD122
Nov 10, 2008 08:04 AM
- XOMA to Announce Third Quarter 2008 Financial Results and Host Conference Call on November 10
Nov 04, 2008 07:01 AM
- XOMA to Present at the Rodman and Renshaw Annual Global Investment Conference on November 11
Nov 04, 2008 07:01 AM
- XOMA Appoints Steve Doberstein to Vice President of Research
Oct 28, 2008 08:06 AM
- XOMA Presents Data On XOMA 052, An Anti-IL-1 Beta Antibody, in Rheumatoid Arthritis and Acute Gout Animal Models
Oct 25, 2008 08:00 PM
- XOMA to Present At the BIO Investor Forum On October 30
Oct 23, 2008 04:35 PM
- XOMA Enters Into $60 Million Committed Equity Financing Facility
Oct 22, 2008 08:05 AM
- XOMA to Webcast Analyst and Investor Event 'Interleukin-1 Blockers: Unlocking Their Potential in Diabetes and Beyond' On September 25
Sep 22, 2008 08:06 AM
- XOMA to Present At the UBS Global Life Sciences Conference On September 22
Sep 16, 2008 04:35 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
XOMA
|
Compare to S&P
|
| YTD |
-72.27 %
|
-54.57 %
|
| 4 Weeks |
-24.80 %
|
-18.72 %
|
| 12 Weeks |
-55.24 %
|
-37.95 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 6.25 %
|
|
EPS Growth in Last Year: -193.75 %
|
|
Sales Growth in Last Quarter: -28.99 %
|
|
Sales Growth in Last Quarter: -81.70 %
|
|
|
